A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Carpenter LL, McDougle CJ, Epperson CN, Price LH. A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder. Drug Saf. 1996 Aug; 15(2):116-34.